Federal attacks on universities and research funding could destroy centuries of progress in innovation, threatening ...

Merck will grow its U.S. manufacturing footprint with a $1 billion plant, making it the latest drugmaker to invest in the U.S ...

A massive blackout affecting Spain, Portugal, and parts of France has been blamed on atmospheric conditions. Now engineers ...

GLP-1 use significantly lowered risk for atrial fibrillation-related events for patients with diabetes, AF and obesity, with ...

With GLP-1 shortage officially over, patients who relied on compounded copies have only bad options to choose from ...

People taking GLP-1 receptor agonists appeared to be at elevated risk of rejection episodes after lung transplantation, a ...

It’s common to feel nervous (and maybe even spaced out) when your doctor demonstrates how to inject yourself with ...

There is a low incidence rate of suicide-related adverse events among adults with diabetes or obesity being treated with GLP-1 RAs.